Home
>
National Drug Code (NDC)
>
Zemaira
Zemaira - 0053-7201-02 - (alpha-1-proteinase inhibitor human)
Drug Information of Zemaira
| Product NDC: | 0053-7201 |
| Proprietary Name: | Zemaira |
| Non Proprietary Name: | alpha-1-proteinase inhibitor human |
| Active Ingredient(s): | & nbsp; alpha-1-proteinase inhibitor human |
| Administration Route(s): | |
| Dosage Form(s): | KIT |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Zemaira
| Product NDC: | 0053-7201 |
| Labeler Name: | CSL Behring LLC |
| Product Type: | PLASMA DERIVATIVE |
| FDA Application Number: | BLA125078 |
| Marketing Category: | BLA |
| Start Marketing Date: | 20030708 |
Package Information of Zemaira
| Package NDC: | 0053-7201-02 |
| Package Description: | 1 KIT in 1 CARTON (0053-7201-02) * 20 mL in 1 VIAL, SINGLE-DOSE (0053-7211-01) * 20 mL in 1 VIAL, SINGLE-DOSE (0053-7653-20) |
NDC Information of Zemaira
| NDC Code | 0053-7201-02 |
| Proprietary Name | Zemaira |
| Package Description | 1 KIT in 1 CARTON (0053-7201-02) * 20 mL in 1 VIAL, SINGLE-DOSE (0053-7211-01) * 20 mL in 1 VIAL, SINGLE-DOSE (0053-7653-20) |
| Product NDC | 0053-7201 |
| Product Type Name | PLASMA DERIVATIVE |
| Non Proprietary Name | alpha-1-proteinase inhibitor human |
| Dosage Form Name | KIT |
| Route Name | |
| Start Marketing Date | 20030708 |
| Marketing Category Name | BLA |
| Labeler Name | CSL Behring LLC |
| Substance Name | |
| Strength Number | |
| Strength Unit | |
| Pharmaceutical Classes |
